Crossmark

Associations Between Wearable-Specific Indicators of Physical Activity Behaviour and Insulin Sensitivity and Glycated Haemoglobin in the General Population: Results from the ORISCAV-LUX 2 Study

Crossref DOI link: https://doi.org/10.1186/s40798-022-00541-9

Published Online: 2022-12-12

Published Print: 2022-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Backes, Anne https://orcid.org/0000-0003-2026-5762
Aguayo, Gloria A. https://orcid.org/0000-0002-5625-1664
Collings, Paul J. https://orcid.org/0000-0003-2022-5453
El Fatouhi, Douae https://orcid.org/0000-0002-8494-6535
Fagherazzi, Guy https://orcid.org/0000-0001-5033-5966
Malisoux, Laurent https://orcid.org/0000-0002-6601-5630
,

Alkerwi, Ala’a

Noppe, Stephanie

Delagardelle, Charles

Beissel, Jean

Chioti, Anna

Stranges, Saverio

Schmit, Jean-Claude

Lair, Marie-Lise

D’Incau, Marylène

Pastore, Jessica

Le Coroller, Gwenaëlle

Aguayo, Gloria A

Appenzeller, Brice

Couffignal, Sophie

Gantenbein, Manon

Devaux, Yvan

Vaillant, Michel

Huiart, Laetitia

Bejko, Dritan

Bohn, Torsten

Samouda, Hanen

Perquin, Magali

Ruiz, Maria

Ernens, Isabelle
License Information

Text and Data Mining valid from 2022-12-01

Version of Record valid from 2022-12-12
More Information

Article History

Received: 3 December 2021

Accepted: 23 November 2022

First Online: 12 December 2022

Declarations

:

: The study was approved by the National Research Ethics Committee (N° 201.505/12) and the National Commission for Private Data Protection (CNPD). All participants were informed about the study details and signed an informed consent.

: Not applicable.

: AB, GA and LM declare that they have no competing interests. GF has received consulting fees from Lilly, MSD, Roche Diabetes Care, AstraZeneca, Diabeloop and Danone Research. DEF is supported by a doctoral grant from the French National Cancer Institute (INCa_13563).

Document is current

Any future updates will be listed below